87 related articles for article (PubMed ID: 20721249)
1. [Effects of clinically effective dose of lovastatin on prostate cancer PC3 cells].
Yang L; Wang Y; Lv TJ; Zhou LQ; Jin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):391-5. PubMed ID: 20721249
[TBL] [Abstract][Full Text] [Related]
2. Drastic Synergy of Lovastatin and
Yao CJ; Chang CL; Hu MH; Liao CH; Lai GM; Chiou TJ; Ho HL; Kuo HC; Yang YY; Whang-Peng J; Chuang SE
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960146
[TBL] [Abstract][Full Text] [Related]
3. Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.
Marcelli M; Cunningham GR; Haidacher SJ; Padayatty SJ; Sturgis L; Kagan C; Denner L
Cancer Res; 1998 Jan; 58(1):76-83. PubMed ID: 9426061
[TBL] [Abstract][Full Text] [Related]
4. The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation.
Siddiqui EJ; Shabbir M; Mikhailidis DP; Thompson CS; Mumtaz FH
J Urol; 2006 Oct; 176(4 Pt 1):1648-53. PubMed ID: 16952708
[TBL] [Abstract][Full Text] [Related]
5. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells.
Wang P; Liu B; Luo JD; Zhang ZG; Ma Q; Chen ZD
Asian J Androl; 2007 May; 9(3):353-60. PubMed ID: 17486276
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin-induced apoptosis in prostate stromal cells.
Padayatty SJ; Marcelli M; Shao TC; Cunningham GR
J Clin Endocrinol Metab; 1997 May; 82(5):1434-9. PubMed ID: 9141529
[TBL] [Abstract][Full Text] [Related]
7. The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells.
Heidarian E; Keloushadi M; Ghatreh-Samani K; Valipour P
Biomed Pharmacother; 2016 Dec; 84():264-269. PubMed ID: 27665471
[TBL] [Abstract][Full Text] [Related]
8. Dryopteris crassirhizoma has anti-cancer effects through both extrinsic and intrinsic apoptotic pathways and G0/G1 phase arrest in human prostate cancer cells.
Chang SH; Bae JH; Hong DP; Choi KD; Kim SC; Her E; Kim SH; Kang CD
J Ethnopharmacol; 2010 Jul; 130(2):248-54. PubMed ID: 20438825
[TBL] [Abstract][Full Text] [Related]
9. [Curcumin-induced the expression of inhibitor kappaBalpha protein in human prostate cancer cells].
Guo H; Yu JH; Chen K; Ye ZQ
Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(18):1256-9. PubMed ID: 17147887
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells.
Liu Y; Chen L; Gong Z; Shen L; Kao C; Hock JM; Sun L; Li X
Oncotarget; 2015 Feb; 6(5):3055-70. PubMed ID: 25605010
[TBL] [Abstract][Full Text] [Related]
11. Berberine inhibits the proliferation of prostate cancer cells and induces G₀/G₁ or G₂/M phase arrest at different concentrations.
Lu W; Du S; Wang J
Mol Med Rep; 2015 May; 11(5):3920-4. PubMed ID: 25572870
[TBL] [Abstract][Full Text] [Related]
12. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
[TBL] [Abstract][Full Text] [Related]
13. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
Hoque A; Chen H; Xu XC
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
[TBL] [Abstract][Full Text] [Related]
14. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
Li L; Zhu Z; Joshi B; Porter AT; Tang DG
Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
[TBL] [Abstract][Full Text] [Related]
15. [Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro].
Zhang H; Lü JJ; Gao QZ; Zhang J
Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):382-5. PubMed ID: 16638347
[TBL] [Abstract][Full Text] [Related]
16. [Quinoline derivative PQ1 combined with cisplatin promotes the proliferation and gap junction communication of prostate cancer PC3 cells].
Lin YZ; Xu N; Li XD; Xue XY; Cai H; Wei Y; Zheng QS
Zhonghua Nan Ke Xue; 2016 Feb; 22(2):116-21. PubMed ID: 26939394
[TBL] [Abstract][Full Text] [Related]
17. Lovastatin-induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal.
Niknejad N; Gorn-Hondermann I; Ma L; Zahr S; Johnson-Obeseki S; Corsten M; Dimitroulakos J
Int J Cancer; 2014 Jan; 134(2):268-79. PubMed ID: 23824972
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin induces apoptosis in malignant mesothelioma cells.
Rubins JB; Greatens T; Kratzke RA; Tan AT; Polunovsky VA; Bitterman P
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1616-22. PubMed ID: 9603146
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin enhances chemosensitivity of paclitaxel-resistant prostate cancer cells through inhibition of CYP2C8.
Li Y; Chen S; Zhu J; Zheng C; Wu M; Xue L; He G; Fu S; Deng X
Biochem Biophys Res Commun; 2022 Jan; 589():85-91. PubMed ID: 34896780
[TBL] [Abstract][Full Text] [Related]
20. A novel PI3K inhibitor displays potent preclinical activity against an androgen-independent and PTEN-deficient prostate cancer model established from the cell line PC3.
Shi M; Zhou X; Zhang Z; Wang M; Chen G; Han K; Cao B; Liu Z; Mao X
Toxicol Lett; 2014 Aug; 228(3):133-9. PubMed ID: 24831963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
